Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.7K Sell
11,221
-2,128
-16% -$6.65K ﹤0.01% 371
2026
Q1
$38.3K Buy
+13,349
New +$38.1K 0.01% 314
2025
Q4
Sell
-13,737
Closed -$30.6K 287
2025
Q3
$30.6K Hold
13,737
﹤0.01% 270
2025
Q2
$34.2K Buy
+13,737
New +$33.4K ﹤0.01% 256
2025
Q1
Sell
-14,107
Closed -$25.7K 89
2024
Q4
$25.7K Buy
14,107
+2,867
+26% +$6.34K ﹤0.01% 222
2024
Q3
$27K Hold
11,240
﹤0.01% 223
2024
Q2
$23.5K Buy
+11,240
New +$25.6K ﹤0.01% 207

Other funds holding ABEV

Symphony Financial's ABEV Position: Q2 2026 in Review

Symphony Financial reduced its Ambev (ABEV) stake by 16% in Q2 2026, selling an estimated $6.65K and leaving 11,221 shares worth $35.7K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

Symphony Financial first reported a position in ABEV in Q2 2024 and has held it in 7 quarters since. The position peaked at $38.3K in Q1 2026. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Symphony Financial held 11,221 shares of Ambev worth $35.7K as of Q2 2026.
  • Symphony Financial sold 2,128 Ambev shares in Q2 2026, an estimated $6.65K.
  • Ambev made up ﹤0.01% of Symphony Financial's portfolio in Q2 2026, its #371 holding.
  • Symphony Financial first reported a position in Ambev in Q2 2024 and has held it in 7 quarters since.
  • Symphony Financial's Ambev position peaked at $38.3K in Q1 2026.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.